Eli Lilly Exec Heads to Harvard Medical School
"Does this appointment signify that Harvard Medical School intends to even further strengthen its research ties to the pharmaceutical industry?"
DSM5 Revisions
"Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who’s considered to be normal or not, for who’s considered disabled," said Dr. Michael First, professor of psychiatry at Columbia University who edited the DSM4l but is not involved in the DSM5.
America’s Poor Children Likelier to Get Antipsychotics_NYT
A front page article in The New York Times raises the long-overdue alarms about the forced drugging of American children–in particular poor children who are condemned to ingest toxic neuroleptics (a.k.a. ‘atypical antipsychotics) at a rate four times higher than children whose parents have private insurance. These drugs qualify under…
Americans Hostage to Profit-Driven Healthcare System
America’s profit-driven medical paradigm overdiagnoses illness and garners profits from unnecessary treatment.
Top FDA Officials, Compromised by Conflicts of Interest
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
FDA Approves Another Dangerous Antipsychotic, Asenapine
At the July 30, 2009 FDA advisory committee hearing, the only formal presentations at the meeting were a summary of the safety and efficacy data by the sponsor.
ACRE–A High Powered Harvard Stealth Pharma Front Group
ACRE’s mission is to persuade physicians that MORE rather than less industry involvement in Continuing Medical Education programs is good for patients–much as industry’s "Harry and Louise" ads were aimed at convincing the public that universal healthcare was BAD for them.
Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?
Unless the overall treatment and services provided to schizophrenia patients in Finland is unique and especially protective—which the authors do not suggest—their claimed findings of lowered mortality rates for antipsychotic drug users are belied by a consistent body of evidence.
Did FDA Include Evidence of Brain Damage Caused by Antipsychotics?
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage.
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
Marketing Trumps Safety: the case of Antipsychotics
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
Rx for Antipsychotc Drugs for Children Begin To Decelerate_WSJ
This is a result of public awareness–thanks to information uncovered during litigation, by Sen. Charles Grassley’s investigative team, by whistleblowers, and the press!